Screener
Amphastar Pharmaceuticals AMPH Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's inventories?
- Amphastar Pharmaceuticals (AMPH) reported inventories of $179.91M in Q2 2026.
- How has Amphastar Pharmaceuticals's inventories changed year-over-year?
- Amphastar Pharmaceuticals's inventories decreased by 6.2% year-over-year, from $191.73M to $179.91M.
- What is the long-term trend for Amphastar Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's inventories has grown at a 12.8% compound annual growth rate (CAGR), from $96.83M to $176.89M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Amphastar Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude